Profilo
Stephen S.
Yoder is currently Co-Managing Director at Pieris Pharmaceuticals GmbH.
Former positions include President & Chief Executive Officer at Marika, Inc., President, Chief Executive Officer & Director at Pieris AG, President, Chief Executive Officer & Director at Pieris Pharmaceuticals, Inc. from 2014 to 2024, Chief Executive Officer at Palvella Therapeutics, Inc., and General Counsel at MorphoSys AG from 1999 to 2010.
Education includes undergraduate studies at Grove City College and graduate studies at George Washington University Law School.
Posizioni attive di Stephen Yoder
| Società | Posizione | Inizio |
|---|---|---|
Pieris Pharmaceuticals GmbH
Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Operates as a biotechnology company | Amministratore Delegato | - |
Precedenti posizioni note di Stephen Yoder
| Società | Posizione | Fine |
|---|---|---|
| PIERIS PHARMACEUTICALS | Amministratore Delegato | 13/12/2024 |
| MORPHOSYS AG | Consigliere Generale | - |
Marika, Inc.
Marika, Inc. Personnel ServicesCommercial Services Provides online job marketplace services | Amministratore Delegato | - |
Pieris AG
Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Amministratore Delegato | - |
Formazione di Stephen Yoder
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Marika, Inc.
Marika, Inc. Personnel ServicesCommercial Services Provides online job marketplace services | Commercial Services |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Grove City College
Grove City College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris AG
Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Health Technology |
George Washington University Law School
George Washington University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris Pharmaceuticals, Inc.
Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
Pieris Pharmaceuticals GmbH
Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
















